What if the things you do just for fun were doing more than entertaining you? Hidden beneath the laughter, focus, and ...
The triplet regimen of azacitidine, venetoclax, and tagraxofusp showed high complete response rates in both untreated and relapsed/refractory BPDCN patients. Safety profile of the triplet was ...
ORLANDO, DECEMBER 8, 2025 – Researchers from The University of Texas MD Anderson Cancer Center presented promising new data from two ongoing studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback